Meijer P - Search Results

1

Response to activated protein C in subjects with and without dementia. The Dutch Vascular Factors in Dementia Study.

Bots ML, van Kooten F, Breteler MM, Slagboom PE, Hofman A, Haverkate F, Meijer P, Koudstaal PJ, Grobbee DE, Kluft C. Bots ML, et al. Among authors: meijer p. Haemostasis. 1998 May-Aug;28(3-4):209-15. doi: 10.1159/000022432. Haemostasis. 1998. PMID: 10420068

2

Reduced response to activated protein C is associated with increased risk for cerebrovascular disease.

van der Bom JG, Bots ML, Haverkate F, Slagboom PE, Meijer P, de Jong PT, Hofman A, Grobbee DE, Kluft C. van der Bom JG, et al. Among authors: meijer p. Ann Intern Med. 1996 Aug 15;125(4):265-9. doi: 10.7326/0003-4819-125-4-199608150-00002. Ann Intern Med. 1996. PMID: 8678388

3

Tissue plasminogen activator and risk of myocardial infarction. The Rotterdam Study.

van der Bom JG, de Knijff P, Haverkate F, Bots ML, Meijer P, de Jong PT, Hofman A, Kluft C, Grobbee DE. van der Bom JG, et al. Among authors: meijer p. Circulation. 1997 Jun 17;95(12):2623-7. doi: 10.1161/01.cir.95.12.2623. Circulation. 1997. PMID: 9193430

4

Coagulation and fibrinolysis markers and risk of dementia. The Dutch Vascular Factors in Dementia Study.

Bots ML, Breteler MM, van Kooten F, Haverkate F, Meijer P, Koudstaal PJ, Grobbee DE, Kluft C. Bots ML, et al. Among authors: meijer p. Haemostasis. 1998 May-Aug;28(3-4):216-22. doi: 10.1159/000022433. Haemostasis. 1998. PMID: 10420069

5

Activation products of the haemostatic system in coronary, cerebrovascular and peripheral arterial disease.

van der Bom JG, Bots ML, Haverkate F, Meijer P, Hofman A, Kluft C, Grobbee DE. van der Bom JG, et al. Among authors: meijer p. Thromb Haemost. 2001 Feb;85(2):234-9. Thromb Haemost. 2001. PMID: 11246539

6

Performance goals for the laboratory testing of antithrombin, protein C and protein S.

Meijer P, Haverkate F, Kluft C. Meijer P, et al. Thromb Haemost. 2006 Nov;96(5):584-9. Thromb Haemost. 2006. PMID: 17080214

7

The long-term within- and between-laboratory variability for assay of antithrombin, and proteins C and S: results derived from the external quality assessment program for thrombophilia screening of the ECAT Foundation.

Meijer P, Kluft C, Haverkate F, De Maat MP. Meijer P, et al. J Thromb Haemost. 2003 Apr;1(4):748-53. doi: 10.1046/j.1538-7836.2003.00141.x. J Thromb Haemost. 2003. PMID: 12871411 Free article.

8

A model for the harmonisation of test results of different quantitative D-dimer methods.

Meijer P, Haverkate F, Kluft C, de Moerloose P, Verbruggen B, Spannagl M. Meijer P, et al. Thromb Haemost. 2006 Mar;95(3):567-72. doi: 10.1160/TH05-01-0042. Thromb Haemost. 2006. PMID: 16525589 Free article.

9

Biological variation in tPA-induced plasma clot lysis time.

Talens S, Malfliet JJ, Rudež G, Spronk HM, Janssen NA, Meijer P, Kluft C, de Maat MP, Rijken DC. Talens S, et al. Among authors: meijer p. Thromb Haemost. 2012 Oct;108(4):640-6. doi: 10.1160/TH12-02-0124. Epub 2012 Jul 26. Thromb Haemost. 2012. PMID: 22836204

10

Acquired activated protein-C resistance.

Kluft C, Meijer P, Gram J, Jespersen J. Kluft C, et al. Among authors: meijer p. Lancet. 1999 May 29;353(9167):1882. doi: 10.1016/S0140-6736(05)75086-8. Lancet. 1999. PMID: 10359437 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

255 results

Search Page

Filters